Simba Gill insider trades: Evelo Biosciences (EVLO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Simba reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | EVLO | ↓ Sell | 172 | $0.33 | $57 | Direct | Nov 8, 2023 (0d) |
| Sep 28, 2023 | EVLO | ↓ Sell | 1,996 | $3.94 | $8K | Direct | Sep 29, 2023 (1d) |
| Aug 8, 2023 | EVLO | ↓ Sell | 342 | $9.51 | $3K | Direct | Aug 9, 2023 (1d) |
| May 8, 2023 | EVLO | ↓ Sell | 3,537 | $0.13 | $444 | Direct | May 10, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Simba Gill's insider trades
Simba Gill is President & CEO at Evelo Biosciences (EVLO). Since May 8, 2023, Simba has reported no open-market purchases and 4 sales worth $12K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.